LCKLSL

Tax included
LCKLSL is a N-terminal hexapeptide and a competitive annexin A2 (AnxA2) inhibitor. LCKLSL potently inhibits the binding of tissue plasminogen activator (tPA) to AnxA2. LCKLSL also inhibits the generation of plasmin and has anti-angiogenic roles.
MedChemExpress 
HY-P2333

Data sheet

Size
Multiple sizes
Reactivity
Others
Application
Neuroscience-Neuromodulation
CAS
533902-29-3